Critical Care Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Critical Care Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Albumin
1.2.3 Prothrombin Complex Concentrates
1.2.4 Antithrombin Concentrates
1.2.5 Factor XIII Concentrates
1.2.6 Fibrinogen Concentrates
1.3 Market by Application
1.3.1 Global Critical Care Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pulmonary Embolism (PE)
1.3.3 Acute Coronary Syndrome
1.3.4 Atrial Fibrillation
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Critical Care Therapeutics Market Perspective (2017-2028)
2.2 Critical Care Therapeutics Growth Trends by Region
2.2.1 Critical Care Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Critical Care Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Critical Care Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Critical Care Therapeutics Market Dynamics
2.3.1 Critical Care Therapeutics Industry Trends
2.3.2 Critical Care Therapeutics Market Drivers
2.3.3 Critical Care Therapeutics Market Challenges
2.3.4 Critical Care Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Critical Care Therapeutics Players by Revenue
3.1.1 Global Top Critical Care Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Critical Care Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Critical Care Therapeutics Revenue
3.4 Global Critical Care Therapeutics Market Concentration Ratio
3.4.1 Global Critical Care Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Critical Care Therapeutics Revenue in 2021
3.5 Critical Care Therapeutics Key Players Head office and Area Served
3.6 Key Players Critical Care Therapeutics Product Solution and Service
3.7 Date of Enter into Critical Care Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Critical Care Therapeutics Breakdown Data by Type
4.1 Global Critical Care Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Critical Care Therapeutics Forecasted Market Size by Type (2023-2028)
5 Critical Care Therapeutics Breakdown Data by Application
5.1 Global Critical Care Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Critical Care Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Critical Care Therapeutics Market Size (2017-2028)
6.2 North America Critical Care Therapeutics Market Size by Type
6.2.1 North America Critical Care Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Critical Care Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Critical Care Therapeutics Market Share by Type (2017-2028)
6.3 North America Critical Care Therapeutics Market Size by Application
6.3.1 North America Critical Care Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Critical Care Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Critical Care Therapeutics Market Share by Application (2017-2028)
6.4 North America Critical Care Therapeutics Market Size by Country
6.4.1 North America Critical Care Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Critical Care Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Critical Care Therapeutics Market Size (2017-2028)
7.2 Europe Critical Care Therapeutics Market Size by Type
7.2.1 Europe Critical Care Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Critical Care Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Critical Care Therapeutics Market Share by Type (2017-2028)
7.3 Europe Critical Care Therapeutics Market Size by Application
7.3.1 Europe Critical Care Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Critical Care Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Critical Care Therapeutics Market Share by Application (2017-2028)
7.4 Europe Critical Care Therapeutics Market Size by Country
7.4.1 Europe Critical Care Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Critical Care Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Critical Care Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Critical Care Therapeutics Market Size by Type
8.2.1 Asia-Pacific Critical Care Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Critical Care Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Critical Care Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Critical Care Therapeutics Market Size by Application
8.3.1 Asia-Pacific Critical Care Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Critical Care Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Critical Care Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Critical Care Therapeutics Market Size by Region
8.4.1 Asia-Pacific Critical Care Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Critical Care Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Critical Care Therapeutics Market Size (2017-2028)
9.2 Latin America Critical Care Therapeutics Market Size by Type
9.2.1 Latin America Critical Care Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Critical Care Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Critical Care Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Critical Care Therapeutics Market Size by Application
9.3.1 Latin America Critical Care Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Critical Care Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Critical Care Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Critical Care Therapeutics Market Size by Country
9.4.1 Latin America Critical Care Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Critical Care Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Critical Care Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Critical Care Therapeutics Market Size by Type
10.2.1 Middle East & Africa Critical Care Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Critical Care Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Critical Care Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Critical Care Therapeutics Market Size by Application
10.3.1 Middle East & Africa Critical Care Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Critical Care Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Critical Care Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Critical Care Therapeutics Market Size by Country
10.4.1 Middle East & Africa Critical Care Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Critical Care Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Critical Care Therapeutics Introduction
11.1.4 CSL Behring Revenue in Critical Care Therapeutics Business (2017-2022)
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Critical Care Therapeutics Introduction
11.2.4 Grifols Revenue in Critical Care Therapeutics Business (2017-2022)
11.2.5 Grifols Recent Developments
11.3 Kedrion Biopharma
11.3.1 Kedrion Biopharma Company Details
11.3.2 Kedrion Biopharma Business Overview
11.3.3 Kedrion Biopharma Critical Care Therapeutics Introduction
11.3.4 Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2017-2022)
11.3.5 Kedrion Biopharma Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Critical Care Therapeutics Introduction
11.4.4 Octapharma Revenue in Critical Care Therapeutics Business (2017-2022)
11.4.5 Octapharma Recent Developments
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Critical Care Therapeutics Introduction
11.5.4 Takeda Revenue in Critical Care Therapeutics Business (2017-2022)
11.5.5 Takeda Recent Developments
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Details
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Critical Care Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Critical Care Therapeutics Business (2017-2022)
11.6.5 Bayer HealthCare Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Critical Care Therapeutics Introduction
11.7.4 Merck Revenue in Critical Care Therapeutics Business (2017-2022)
11.7.5 Merck Recent Developments
11.8 Mitsubishi Tanabe Pharma
11.8.1 Mitsubishi Tanabe Pharma Company Details
11.8.2 Mitsubishi Tanabe Pharma Business Overview
11.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Introduction
11.8.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2017-2022)
11.8.5 Mitsubishi Tanabe Pharma Recent Developments
11.9 REVO Biologics
11.9.1 REVO Biologics Company Details
11.9.2 REVO Biologics Business Overview
11.9.3 REVO Biologics Critical Care Therapeutics Introduction
11.9.4 REVO Biologics Revenue in Critical Care Therapeutics Business (2017-2022)
11.9.5 REVO Biologics Recent Developments
11.10 Rockwell Medical
11.10.1 Rockwell Medical Company Details
11.10.2 Rockwell Medical Business Overview
11.10.3 Rockwell Medical Critical Care Therapeutics Introduction
11.10.4 Rockwell Medical Revenue in Critical Care Therapeutics Business (2017-2022)
11.10.5 Rockwell Medical Recent Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Critical Care Therapeutics Introduction
11.11.4 Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2017-2022)
11.11.5 Thermo Fisher Scientific Recent Developments
11.12 Shanghai RAAS
11.12.1 Shanghai RAAS Company Details
11.12.2 Shanghai RAAS Business Overview
11.12.3 Shanghai RAAS Critical Care Therapeutics Introduction
11.12.4 Shanghai RAAS Revenue in Critical Care Therapeutics Business (2017-2022)
11.12.5 Shanghai RAAS Recent Developments
11.13 China Biologic Products
11.13.1 China Biologic Products Company Details
11.13.2 China Biologic Products Business Overview
11.13.3 China Biologic Products Critical Care Therapeutics Introduction
11.13.4 China Biologic Products Revenue in Critical Care Therapeutics Business (2017-2022)
11.13.5 China Biologic Products Recent Developments
11.14 Cosmo Pharmaceuticals
11.14.1 Cosmo Pharmaceuticals Company Details
11.14.2 Cosmo Pharmaceuticals Business Overview
11.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Introduction
11.14.4 Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2017-2022)
11.14.5 Cosmo Pharmaceuticals Recent Developments
11.15 King Pharmaceuticals
11.15.1 King Pharmaceuticals Company Details
11.15.2 King Pharmaceuticals Business Overview
11.15.3 King Pharmaceuticals Critical Care Therapeutics Introduction
11.15.4 King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2017-2022)
11.15.5 King Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Critical Care Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Albumin
Table 3. Key Players of Prothrombin Complex Concentrates
Table 4. Key Players of Antithrombin Concentrates
Table 5. Key Players of Factor XIII Concentrates
Table 6. Key Players of Fibrinogen Concentrates
Table 7. Global Critical Care Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Critical Care Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Critical Care Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Critical Care Therapeutics Market Share by Region (2017-2022)
Table 11. Global Critical Care Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Critical Care Therapeutics Market Share by Region (2023-2028)
Table 13. Critical Care Therapeutics Market Trends
Table 14. Critical Care Therapeutics Market Drivers
Table 15. Critical Care Therapeutics Market Challenges
Table 16. Critical Care Therapeutics Market Restraints
Table 17. Global Critical Care Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Critical Care Therapeutics Revenue Share by Players (2017-2022)
Table 19. Global Top Critical Care Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2021)
Table 20. Ranking of Global Top Critical Care Therapeutics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Critical Care Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Critical Care Therapeutics Product Solution and Service
Table 24. Date of Enter into Critical Care Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Critical Care Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Critical Care Therapeutics Revenue Market Share by Type (2017-2022)
Table 28. Global Critical Care Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Critical Care Therapeutics Revenue Market Share by Type (2023-2028)
Table 30. Global Critical Care Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Critical Care Therapeutics Revenue Share by Application (2017-2022)
Table 32. Global Critical Care Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Critical Care Therapeutics Revenue Share by Application (2023-2028)
Table 34. North America Critical Care Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Critical Care Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Critical Care Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Critical Care Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Critical Care Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Critical Care Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Critical Care Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Critical Care Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Critical Care Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Critical Care Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Critical Care Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Critical Care Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Critical Care Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Critical Care Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Critical Care Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Critical Care Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Critical Care Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Critical Care Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Critical Care Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Critical Care Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Critical Care Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Critical Care Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Critical Care Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Critical Care Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Critical Care Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Critical Care Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Critical Care Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Critical Care Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Critical Care Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Critical Care Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 64. CSL Behring Company Details
Table 65. CSL Behring Business Overview
Table 66. CSL Behring Critical Care Therapeutics Product
Table 67. CSL Behring Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 68. CSL Behring Recent Developments
Table 69. Grifols Company Details
Table 70. Grifols Business Overview
Table 71. Grifols Critical Care Therapeutics Product
Table 72. Grifols Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Grifols Recent Developments
Table 74. Kedrion Biopharma Company Details
Table 75. Kedrion Biopharma Business Overview
Table 76. Kedrion Biopharma Critical Care Therapeutics Product
Table 77. Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 78. Kedrion Biopharma Recent Developments
Table 79. Octapharma Company Details
Table 80. Octapharma Business Overview
Table 81. Octapharma Critical Care Therapeutics Product
Table 82. Octapharma Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 83. Octapharma Recent Developments
Table 84. Takeda Company Details
Table 85. Takeda Business Overview
Table 86. Takeda Critical Care Therapeutics Product
Table 87. Takeda Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Takeda Recent Developments
Table 89. Bayer HealthCare Company Details
Table 90. Bayer HealthCare Business Overview
Table 91. Bayer HealthCare Critical Care Therapeutics Product
Table 92. Bayer HealthCare Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 93. Bayer HealthCare Recent Developments
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Critical Care Therapeutics Product
Table 97. Merck Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Merck Recent Developments
Table 99. Mitsubishi Tanabe Pharma Company Details
Table 100. Mitsubishi Tanabe Pharma Business Overview
Table 101. Mitsubishi Tanabe Pharma Critical Care Therapeutics Product
Table 102. Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Mitsubishi Tanabe Pharma Recent Developments
Table 104. REVO Biologics Company Details
Table 105. REVO Biologics Business Overview
Table 106. REVO Biologics Critical Care Therapeutics Product
Table 107. REVO Biologics Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 108. REVO Biologics Recent Developments
Table 109. Rockwell Medical Company Details
Table 110. Rockwell Medical Business Overview
Table 111. Rockwell Medical Critical Care Therapeutics Product
Table 112. Rockwell Medical Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 113. Rockwell Medical Recent Developments
Table 114. Thermo Fisher Scientific Company Details
Table 115. Thermo Fisher Scientific Business Overview
Table 116. Thermo Fisher Scientific Critical Care Therapeutics Product
Table 117. Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 118. Thermo Fisher Scientific Recent Developments
Table 119. Shanghai RAAS Company Details
Table 120. Shanghai RAAS Business Overview
Table 121. Shanghai RAAS Critical Care Therapeutics Product
Table 122. Shanghai RAAS Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 123. Shanghai RAAS Recent Developments
Table 124. China Biologic Products Company Details
Table 125. China Biologic Products Business Overview
Table 126. China Biologic Products Critical Care Therapeutics Product
Table 127. China Biologic Products Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 128. China Biologic Products Recent Developments
Table 129. Cosmo Pharmaceuticals Company Details
Table 130. Cosmo Pharmaceuticals Business Overview
Table 131. Cosmo Pharmaceuticals Critical Care Therapeutics Product
Table 132. Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 133. Cosmo Pharmaceuticals Recent Developments
Table 134. King Pharmaceuticals Company Details
Table 135. King Pharmaceuticals Business Overview
Table 136. King Pharmaceuticals Critical Care Therapeutics Product
Table 137. King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2017-2022) & (US$ Million)
Table 138. King Pharmaceuticals Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Critical Care Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Albumin Features
Figure 3. Prothrombin Complex Concentrates Features
Figure 4. Antithrombin Concentrates Features
Figure 5. Factor XIII Concentrates Features
Figure 6. Fibrinogen Concentrates Features
Figure 7. Global Critical Care Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Pulmonary Embolism (PE) Case Studies
Figure 9. Acute Coronary Syndrome Case Studies
Figure 10. Atrial Fibrillation Case Studies
Figure 11. Other Case Studies
Figure 12. Critical Care Therapeutics Report Years Considered
Figure 13. Global Critical Care Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Critical Care Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Critical Care Therapeutics Market Share by Region: 2021 VS 2028
Figure 16. Global Critical Care Therapeutics Market Share by Players in 2021
Figure 17. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Critical Care Therapeutics Revenue in 2021
Figure 19. North America Critical Care Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Critical Care Therapeutics Market Size Market Share by Type (2017-2028)
Figure 21. North America Critical Care Therapeutics Market Size Market Share by Application (2017-2028)
Figure 22. North America Critical Care Therapeutics Market Size Share by Country (2017-2028)
Figure 23. United States Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Critical Care Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Critical Care Therapeutics Market Size Market Share by Type (2017-2028)
Figure 27. Europe Critical Care Therapeutics Market Size Market Share by Application (2017-2028)
Figure 28. Europe Critical Care Therapeutics Market Size Share by Country (2017-2028)
Figure 29. Germany Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Critical Care Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Critical Care Therapeutics Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Critical Care Therapeutics Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Critical Care Therapeutics Market Size Share by Region (2017-2028)
Figure 39. China Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Critical Care Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Critical Care Therapeutics Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Critical Care Therapeutics Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Critical Care Therapeutics Market Size Share by Country (2017-2028)
Figure 49. Mexico Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Critical Care Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Critical Care Therapeutics Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Critical Care Therapeutics Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Critical Care Therapeutics Market Size Share by Country (2017-2028)
Figure 55. Turkey Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Critical Care Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. CSL Behring Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 59. Grifols Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 60. Kedrion Biopharma Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 61. Octapharma Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 62. Takeda Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 63. Bayer HealthCare Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 65. Mitsubishi Tanabe Pharma Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 66. REVO Biologics Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 67. Rockwell Medical Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 69. Shanghai RAAS Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 70. China Biologic Products Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 71. Cosmo Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 72. King Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Industry Market Size
